M&As this week: Nivalis Therapeutics, Medidata Solutions


Nautilus Merger Sub, a subsidiary of US-based pharmaceutical company, Nivalis Therapeutics, has reached a reverse takeover agreement to acquire Alpine Immune Sciences.

Also based in the US, the target company is a biotechnology company.

Nivalis expects the acquisition to help accelerate development of novel immunotherapies in inflammation and immuno-oncology space.

"Medidata Solutions is set to acquire Mytrus, which will help the former to improve patient engagement by providing tools, data and insights for patients and researchers."

Medidata Solutions is set to acquire Mytrus, which will help the former to improve patient engagement by providing tools, data and insights for patients and researchers.

The acquirer company provides cloud-based solutions and data analytics for clinical research, while the target company is an e-clinical technology company.

Both companies involved in the acquisition are based in the US.